Result
€397,140 ▲ 64.6%
The result rose in 2025 from €241,232 to €397,140.
PHARMA BIEN-ÊTRE
Lifetime
4 annual accounts with figures on one time axispeak €565,872 (2025)
€565,872▲ 160%
peak €397,140 (2025)
€397,140▲ 64.6%
peak €1.2m (2025)
€1.2m▲ 51.6%
€3.7m▲ 7.7%
peak 3.1 FTE (2025)
3.1 FTE
Board1 name since 2021
1 directorTILMAN Mikael, Jacques, Bruno
Documentsfilings and deeds
30-06-202631 days before the deadline
2025financial year
Gross margin from €217,944 to €565,872Result from €241,232 to €397,140Registered office moved from Namur to Jambes 13-08Equity from €770,117 to €1.2mInvestments €344,834Cash from €45,253 to €194,034
Key points
from the 2025 annual accountsDebts
€3.7m 76% of the balance sheet
Financial debts 75%Suppliers 0%Taxes and wages 2%Other 23%
€3.4m of the debts are secured on the company's own assets. In 2022 that was €1.8m.
Investments
€194,834 12.6 × depreciation
Green is investment, beige is depreciation. Land and buildings stand 41.7% higher than in 2024.
Liquidity
1.13 was 0.73 in 2024
Short-term debts rose from €357,601 to €524,142.
Group
4 companies controlled
Heads a group.
Position in the sector
23.9%
Lower solvency than 80% of companies in financial services. Sector median 61.1% · 3,042 companies.
Financial institution: outside the modelBankruptcy probability: sector outside the model
Checked score
Outside the general model
Model not applicable to financial institutions
The Checked score measures liquidity, leverage and margins against the norms for trading and manufacturing companies. A bank, insurer or financial holding has a very different balance sheet. Those ratios and the score mean nothing here. So there is no financial strength either.
Bankruptcy probability within 12 months
The company is a financial institution: a bank, insurer or financial holding. Its balance sheet works differently from that of a trading or manufacturing company. A bankruptcy probability from the general model would mislead here.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
1 signal, which does not raise the risk
1 signal.
neutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-06-2026, 31 days ahead of the deadline.
NBB · 4 filingsDeviation from the deadline
2025
31 days early
2024
13 days early
2023
34 days early
2022
32 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 4 accounts on average 28 days before the deadline. In the sector (NACE 64), the median for financial year 2024 was 14 days before the deadline, and 28% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 30 June (4 of the last 4 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
09-11-2026 today31-12-2026 year end31-07-2027 deadline
Board and ownership
- TILMAN Mikael, Jacques, Bruno 2,000 sharesdeed of 03-11-2021
Shares in 4 companies, including PHARMACIE HUART and PHARMACIE TILMAN
Board & ownershipRecent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0776600905
Registered office moved from Namur to Jambes
New registered office: Rue de Sedent 205, boîte 21 à 5100 Jambes · Previous registered office: Chemin des Mélèzes 15, 5000 Namur · Board meeting of 16-07-2025 · Gazette deed
Registered office moved from Bomal-sur-Ourthe to Namur
New registered office: Chemin des mélèzes 15 à 5000 Namur · Previous registered office: Rue de Fleurie 1, 6941 Bomal-sur-Ourthe · Board meeting of 26-01-2023 · Gazette deed
Incorporation
Founding capital of €200,000, 2,000 shares · Appointment: TILMAN Mikael, Jacques, Bruno (sole director) · Capital of €200,000, 2,000 shares · published on 03-11-2021 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| PHARMA BIEN-ÊTRE Namur | €4.9m | €565,872 | 23.9% | 3.1 |
| ANMA Bruges | €5.0m | €597,655 | 63.3% | 3 |
| DEBLAERE HOLDING Wingene | €7.7m | €686,496 | 31.4% | 3.7 |
| met Apotheken Bree | €8.0m | €434,700 | 16.0% | 2.6 |
| UNIFIRE Ghent | €5.6m | €580,103 | 96.1% | 1.9 |
| Copains.group La Louvière | €6.3m | €457,510 | 63.9% | 5.3 |
| club4T2 Torhout | €3.8m | €490,491 | 16.1% | 2 |
These companies have the same main activity as PHARMA BIEN-ÊTRE: activities of holding companies (NACE 64210). They are comparable in size and age: total assets between €3.8m and €8m, founded between 2019 and 2022.
Official details
Source: KBO- Status
- Active since 28-10-2021Normal situation
- Activity
- Activities of holding companiesNACE 64210and 4 others
- Joint committee
- 313Pharmacies and pricing offices · annual accounts 2025
- Establishment unit
- 2.323.434.1695100 Namur, since 28-10-2021
- Financial year end
- 31 December
- Peppol
- Reachable since 17-07-2026
Annual accounts 2025
- €4.9m▲ 15.7%
- Employeeson 31-12-2025
- 5
- Filing
- Filed on 30-06-2026, 31 days before the end of the filing period
Companies linked to PHARMA BIEN-ÊTRE
Subsidiaries and holdings
Insights on PHARMA BIEN-ÊTRE
PHARMA BIEN-ÊTRE has existed since 2021. The present size dates from 2025. The gross margin rose that year from €217,944 to €565,872.
Solvency rose in 2025 from 18.3% to 23.9% because of the retained profit.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about PHARMA BIEN-ÊTRE
- What is the company number of PHARMA BIEN-ÊTRE?
- The company number of PHARMA BIEN-ÊTRE is 0776.600.905. The VAT number is the same number with BE in front: BE 0776.600.905.
- Where is PHARMA BIEN-ÊTRE based?
- The registered office is at Rue de Sedent 205, 5100 Namur.Company details
- What does PHARMA BIEN-ÊTRE do?
- According to the KBO register, the main activity is activities of holding companies (NACE 64210).
- What is the legal form of PHARMA BIEN-ÊTRE?
- PHARMA BIEN-ÊTRE is a public limited company (NV).
- When was PHARMA BIEN-ÊTRE founded?
- PHARMA BIEN-ÊTRE was founded on 28-10-2021.
- Is PHARMA BIEN-ÊTRE still active?
- Yes, PHARMA BIEN-ÊTRE is an active enterprise in the KBO register.
- How many employees does PHARMA BIEN-ÊTRE have?
- PHARMA BIEN-ÊTRE had an average of 3.1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does PHARMA BIEN-ÊTRE fall under?
- In its 2025 annual accounts, PHARMA BIEN-ÊTRE states joint committee 313 (Pharmacies and pricing offices).
- What is the turnover of PHARMA BIEN-ÊTRE?
- The turnover in financial year 2025 is ≈ €740,000. This figure is estimated from the gross margin of €565,872 and 34 comparable companies (NACE 64210). It probably lies between €620,000 and €1.2m.
- Is PHARMA BIEN-ÊTRE profitable?
- In financial year 2025, PHARMA BIEN-ÊTRE made a profit of €397,140.
- Where can I find the annual accounts of PHARMA BIEN-ÊTRE?
- PHARMA BIEN-ÊTRE filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of PHARMA BIEN-ÊTRE due?
- PHARMA BIEN-ÊTRE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See what changed in the latest annual accounts.What changed See whether the workforce is growing and whether people stay.Employer check
See how customers, suppliers and banks see your own company and what to improve first.